COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,703 Articles (22,913 medRxiv, 8,790 bioRxiv)

Most recent first Previous |  Page 1077: Articles 10761-10770  | Next

Super-immunity by broadly protective nanobodies to sarbecoviruses
Xiang, Y., Huang, W., Liu, H., Sang, Z., Nambulli, S., Tubiana, J., Williams, K. L., Duprex, P., Schneidman-Duhovny, D., Wilson, I. A., Taylor, D. J., Shi, Y.
10.1101/2021.12.26.474192 — Posted: 2021-12-28
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
Bentley, E. G., Kirby, A., Sharma, P., Kipar, A., Mega, D. F., Bramwell, C., Penrice-Randal, R., Prince, T., Brown, J. C., Zhou, J., Screaton, G. R., Barclay, W. S., Owen, A., Hiscox, J. A., Stewart, J. P.
10.1101/2021.12.26.474085 — Posted: 2021-12-28
Improved binding affinity of the Omicron's spike protein with hACE2 receptor is the key factor behind its increased virulence
Kumar, R., Arul, M. N., Srivastava, V.
10.1101/2021.12.28.474338 — Posted: 2021-12-28
Intranasal inhibitor blocks Omicron and other variants of SARS-CoV-2
Mäkelä, A. R., Ugurlu, H., Hannula, L., Salminen, P., Kant, R., Fagerlund, R., Haveri, A., Strandin, T., Kareinen, L., Hepojoki, J., Levanov, L., Pasternack, A., Naves, R. A., Ritvos, O., Österlund, P., Sironen, T., Vapalahti, O., Kipar, A., Huiskonen, J. T., Rissanen, I., Saksela, K.
10.1101/2021.12.28.474326 — Posted: 2021-12-28
Effect of nebulised BromAc(R) on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19
Pillai, K., Mekkawy, A. H., Valle, S., Akhter, J., Morris, D. L.
10.1101/2021.12.28.474344 — Posted: 2021-12-28
Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation.
Taglauer, E., Dhole, Y., Boateng, J., Snyder-Cappione, J. E., Parker, S. E., Clarke, K., Juttukonda, L., Devera, J., Hunnewell, J., Barnett, E., Jia, H., Yarrington, C., Sabharwal, V., Wachman, E.
10.1101/2021.12.26.472655 — Posted: 2021-12-28
Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses
Zhou, R., To, K. K.-W., Peng, Q., Chan, J. M.-C., Huang, H., Yang, D., Lam, B. H.-S., Chuang, V. W.-M., Cai, J.-P., Liu, N., Au, K.-K., Tsang, O. T.-Y., Yuen, K.-Y., Chen, Z.
10.1101/2021.12.27.474218 — Posted: 2021-12-28
Structural analysis of the Spike of the Omicron SARS-COV-2 variant by Cryo-EM and implications for immune evasion
Ni, D., Lau, K., Turelli, P., Raclot, C., Beckert, B., Nazarov, S., Pojer, F., Myasnikov, A., Stahlberg, H., Trono, D.
10.1101/2021.12.27.474250 — Posted: 2021-12-28
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
Zhou, T., Wang, L., Misasi, J., Pegu, A., Zhang, Y., Harris, D. R., Olia, A. S., Talana, C. A., Yang, E. S., Chen, M., Choe, M., Shi, W., Teng, I.-T., Creanga, A., Jenkins, C., Leung, K., Liu, T., Stancofski, E.-S. D., Stephens, T., Zhang, B., Tsybovsky, Y., Graham, B., Mascola, J. R., Sullivan, N., Kwong, P. D.
10.1101/2021.12.27.474307 — Posted: 2021-12-28
Booster vaccines protect hamsters with waning immunity from Delta VOC infection, disease, and transmission
Potts, K. G., Noyce, R. S., Gafuik, C., John, C. M., Todesco, H. M., De Heuvel, E., Favis, N., Kelly, M. M., Evans, D. H., Mahoney, D. J.
10.1101/2021.12.27.474282 — Posted: 2021-12-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).